Format

Send to

Choose Destination
Europace. 2018 Mar 1;20(3):395-407. doi: 10.1093/europace/eux318.

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.

Author information

1
Institute of Cardiovascular Sciences, University of Birmingham, B15 2TT Birmingham, UK.
2
Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.
3
Atrial Fibrillation NETwork (AFNET), Münster, Germany.
4
St George's University of London, London, UK.
5
School for Cardiovascular Diseases, Maastricht University, The Netherlands.
6
Orebro University Hospital, Orebro, Sweden.
7
The National University Hospital, Reykjavik, Iceland.
8
Oslo University Hospital, Oslo, Norway.
9
Fondazione Cardiocentro Ticino, Lugano, Switzerland.
10
Leiden University Medical Center, Leiden, The Netherlands.
11
University Hospital Zurich, Zurich, Switzerland.
12
Department of Cardiology, Institution of Medical Sciences, Uppsala University, Uppsala, Sweden.
13
University of Mannheim, Mannheim, Germany.
14
DIMES Department, University of Bologna, Bologna, Italy.
15
Odense University Hospital, Odense, Denmark.
16
The Johns Hopkins Hospital, Baltimore, MD, USA.
17
Oxford University, Oxford, UK.
18
Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain.
19
University Hospital Maastricht, Maastricht, The Netherlands.
20
University Duisburg-Essen, Essen, Germany.
21
University Hospital Münster, Münster, Germany.
22
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.
23
University of Sydney, Sydney, Australia.
24
Ludwig-Maximilians-University, Munich, Germany.
25
St Vincenz Krankenhaus, Paderborn, Germany.
26
Pitié-Salpêtrière Hospital, Paris, France.
27
Charité-Universitätsmedizin Berlin, Berlin, Germany.
28
Antwerp University Hospital, Antwerp, Belgium.
29
University of Adelaide, Adelaide, Australia.
30
Ludwig-Maximilians University Clinic, Munich, Germany & DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
31
Bayer HealthCare AG, Berlin, Germany.
32
HaeuslerCharité-Universitätsmedizin Berlin, Berlin, Germany.
33
Hospital-Munich Thalkirchen, Munich, Germany.
34
Aarhus University Hospital, Aarhus, Denmark.
35
Städtisches Klinikum Brandenburg, Brandenburg, Germany.
36
Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey.
37
Maastricht University, Medical Center, Maastricht, The Netherlands.
38
School of Medicine, University of Belgrade, Clinical Centre of Serbia, Belgrade, Serbia.
39
University Heart Center Freiburg, Freiburg, Germany.
40
Bristol-Myers Squibb, Rueil-Malmaison, France.
41
University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
42
University Heart Center Hamburg, Hamburg, Germany.
43
Heart Center Leipzig, University of Leipzig, Leipzig, Germany.
44
Ospedale dell'Angelo, Mestre-Venice, Italy.
45
Heraklion University Hospital, Heraklion, Crete, Greece.
46
Division of Cardiology, Southlake Regional Health Centre, University of Toronto, Toronto, Ontario, Canada.
47
Stroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
48
Roche Diagnostics International Ltd, Rotkreuz, Switzerland.

Abstract

There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population with AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in AF have not been shown to consistently impact on mortality or reduce adverse cardiovascular events. New approaches to AF management, including the use of novel technologies and structured, integrated care, have the potential to enhance clinical phenotyping or result in better treatment selection and stratified therapy. Here, we report the outcomes of the 6th Consensus Conference of the Atrial Fibrillation Network (AFNET) and the European Heart Rhythm Association (EHRA), held at the European Society of Cardiology Heart House in Sophia Antipolis, France, 17-19 January 2017. Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control. Ultimately, these approaches can lead to better outcomes for patients with AF.

PMID:
29300976
DOI:
10.1093/europace/eux318
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for Zurich Open Access Repository and Archive
Loading ...
Support Center